Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery

References

• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–252.
   PubMed Web of Science ®Google Scholar
• Hussain A, Singh S, Sharma D, et al. Elastic liposomes as novel carriers: recent advances in drug delivery. Int J Nanomedicine. 2017;12:5087–5108.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Farshbaf M, Mohammadhosseini M, et al. Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications. Artif Cells Nanomed Biotechnol. 2017;45:788–799.
   PubMed Web of Science ®Google Scholar
• Bedu-Addo FK, Huang L. Effect of matrix lipid chain length on liposomes containing cholesterol and ganglioside GM1: implications in drug delivery. J Pharm Sci. 1996;85:714–719.
   PubMed Web of Science ®Google Scholar
• Qhattal HS, Hye T, Alali A, et al. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano. 2014;8:5423–5440.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu Y, Huang L. Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles. Biomaterials. 2014;35:3027–3034.
   PubMed Web of Science ®Google Scholar
• Eloy JO, Claro DSM, Petrilli R, et al. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf B Biointerfaces. 2014;123:345–363.
   PubMed Web of Science ®Google Scholar
• Haynes MT, Huang L. Maximizing the supported bilayer phenomenon: liposomes comprised exclusively of PEGylated phospholipids for enhanced systemic and lymphatic delivery. ACS Appl Mater Interfaces. 2016;8: 24361–24367.
   PubMed Web of Science ®Google Scholar
• Hervella P, Alonso-Sande M, Ledo F, et al. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties. Curr Top Med Chem. 2014;14: 1115–1123.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng X, Sun Y, et al. RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in vivo. Int J Pharm. 2014;468:133–141.
   PubMed Web of Science ®Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9:12.
   PubMed Web of Science ®Google Scholar
• Azanza JR, Sadada B, Reis J. Liposomal formulations of amphotericin B: differences according to the scientific evidence. Rev Esp Quimioter. 2015;28:275–281.
   PubMed Web of Science ®Google Scholar
• Petersen GH, Alzghari SK, Chee W, et al. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J Control Release. 2016;232:255–264.
   PubMed Web of Science ®Google Scholar
• Teixeira MC, Carbone C, Souto EB. Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery. Prog Lipid Res. 2017; 68:1–11.
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res. 2005;44:68–97.
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Kaasgaard T, et al. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Curr Drug Deliv. 2005;2:353–362.
   PubMedGoogle Scholar
• Jensen SS, Andresen TL, Davidsen J, et al. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. Mol Cancer Ther. 2004;3:1451–1458.
   PubMed Web of Science ®Google Scholar
• Laginha KM, Verwoert S, Charrois GJ, et al. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res. 2005;11: 6944–6949.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5:496–504.
   PubMed Web of Science ®Google Scholar
• Orrantia E, Chang PL. Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp Cell Res. 1990;190:170–174.
   PubMed Web of Science ®Google Scholar
• Batard P, Jordan M, Wurm F. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene. 2001;270:61–68.
   PubMed Web of Science ®Google Scholar
• Bisht S, Bhakta G, Mitra S, et al. pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery. Int J Pharm. 2005;288:157–168.
   PubMed Web of Science ®Google Scholar
• Li J, Chen YC, Tseng YC, et al. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J Control Release. 2010;142:416–421.
   PubMed Web of Science ®Google Scholar
• Cai Y, Yao J. Effect of proteins on the synthesis and assembly of calcium phosphate nanomaterials. Nanoscale. 2010; 2:1842–1848.
   PubMed Web of Science ®Google Scholar
• Li J, Yang Y, Huang L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J Control Release. 2012;158:108–114.
   PubMed Web of Science ®Google Scholar
• Tseng YC, Yang A, Huang L. How does the cell overcome LCP nanoparticle-induced calcium toxicity? Mol Pharm. 2013;10:4391–4395.
   PubMedGoogle Scholar
• Huang JL, Jiang G, Song QX, et al. Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis. Nat Comms. 2017;8:15144.
   PubMed Web of Science ®Google Scholar
• Chen J, Gao P, Yuan S, et al. Oncolytic adenovirus complexes coated with lipids and calcium phosphate for cancer gene therapy. ACS Nano. 2016;10:11548–11560.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang M, Zhang L, et al. Designed synthesis of lipid-coated polyacrylic acid/calcium phosphate nanoparticles as dual ph-responsive drug-delivery vehicles for cancer chemotherapy. Chem Eur J. 2017;23: 6586–6595.
   PubMed Web of Science ®Google Scholar
• Au KM, Satterlee A, Min Y, et al. Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeutic. Biomaterials. 2016;82:178–193.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu P, Sun Y, et al. Preparation and properties of biocompatible PS-PEG/calcium phosphate nanospheres. Nanotoxicology. 2015;9:190–200.
   PubMed Web of Science ®Google Scholar
• Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 1997;4:891–900.
   PubMed Web of Science ®Google Scholar
• Li S, Rizzo MA, Bhattacharya S, et al. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 1998;5:930–937.
   PubMed Web of Science ®Google Scholar
• Li SD, Chen YC, Hackett MJ, et al. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther. 2008;16:163–169.
   PubMed Web of Science ®Google Scholar
• Hu Y, Haynes MT, Wang Y, et al. A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo. ACS Nano. 2013;7:5376–5384.
   PubMed Web of Science ®Google Scholar
• Satterlee AB, Yuan H, Huang L. A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging. J Control Release. 2015;217:170–182.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Schwerbrock NM, Rogers AB, et al. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. Mol Ther. 2013;21:1559–1569.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng L, Mumper RJ, et al. Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials. 2013;34:8459–8468.
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, et al. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5:505–515.
   PubMed Web of Science ®Google Scholar
• Tang J, Li L, Howard CB, et al. Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells. J Mater Chem B. 2015;3:6805–6812.
   PubMed Web of Science ®Google Scholar
• Zhou C, Yu B, Yang X, et al. Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm. 2010; 392:201–208.
   PubMedGoogle Scholar
• Maitani Y, Igarashi S, Sato M, et al. Cationic liposome (DC-Chol/DOPE =1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. Int J Pharm. 2007;342:33–39.
   PubMed Web of Science ®Google Scholar
• Khatri N, Baradia D, Vhora I, et al. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells. J Control Release. 2014;182:45–57.
   PubMed Web of Science ®Google Scholar
• Guo S, Wang Y, Miao L, et al. Lipid-coated cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy. ACS Nano. 2013;7:9896–9904.
   PubMed Web of Science ®Google Scholar
• Guo S, Wang Y, Miao L, et al. Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy. Biomaterials. 2014;35:7647–7653.
   PubMed Web of Science ®Google Scholar
• Guo S, Miao L, Wang Y, et al. Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy. J Control Release. 2014; 174:137–142.
   PubMed Web of Science ®Google Scholar
• Srinivas R, Satterlee A, Wang Y, et al. Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging. Nanoscale. 2015;7:18542–18551.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhu YJ, Chen F, et al. Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers. Dalton Trans. 2013; 42:7032–7040.
   PubMed Web of Science ®Google Scholar
• Zhao D, Wang CQ, Zhuo RX, et al. Modification of nanostructured calcium carbonate for efficient gene delivery. Colloids Surf B Biointerfaces. 2014;118:111–116.
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhai K, Pei P, et al. Encapsulation of cisplatin in a PEGylated calcium phosphate nanoparticle (CPNP) for enhanced cytotoxicity to cancerous cells. J Colloid Interface Sci. 2017;493:181–189.
   PubMed Web of Science ®Google Scholar
• Pittella F, Cabral H, Maeda Y, et al. Systemic siRNA delivery to a spontaneous pancreatic tumor model in transgenic mice by PEGylated calcium phosphate hybrid micelles. J Control Release. 2014;178:18–24.
   PubMed Web of Science ®Google Scholar
• Lee K, Oh MH, Lee MS, et al. Stabilized calcium phosphate nano-aggregates using a dopa-chitosan conjugate for gene delivery. Int J Pharm. 2013;445:196–202.
   PubMed Web of Science ®Google Scholar
• Pittella F, Zhang M, Lee Y, et al. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity. Biomaterials. 2011;32:3106–3114.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Kennell C, Lee JY, et al. Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors. Nanomedicine. 2017;13:403–410.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huang L. Lipid nanoparticles for gene delivery. Adv Genet. 2014;88:13–36.
   PubMed Web of Science ®Google Scholar
• Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol. 2000;2:70–75.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hu Y, Wang Y, et al. Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer. Mol Pharm. 2012;9:2280–2289.
   Google Scholar
• Yang Y, Li J, Liu F, et al. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis. Mol Ther. 2012;20:609–615.
   PubMed Web of Science ®Google Scholar
• Chen L, Watson C, Morsch M, et al. Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium phosphate-lipid nanoparticles. Front Neurosci. 2017;11:476.
   PubMed Web of Science ®Google Scholar
• Cohen ZR, Ramishetti S, Peshes-Yaloz N, et al. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. ACS Nano. 2015;9:1581–1591.
   PubMed Web of Science ®Google Scholar
• Wang L, Hao Y, Li H, et al. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles. J Drug Target. 2015;23:832–846.
   PubMed Web of Science ®Google Scholar
• Liu Y, Miao C, Wang Z, et al. Survivin small interfering RNA suppresses glioblastoma growth by inducing cellular apoptosis. Neural Regen Res. 2012;7:924–931.
   PubMed Web of Science ®Google Scholar
• Jensen SA, Day ES, Ko CH, et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med. 2013;5:152r–209r.
   Web of Science ®Google Scholar
• Goodwin TJ, Zhou Y, Musetti SN, et al. Local and transient gene expression primes the liver to resist cancer metastasis. Sci Transl Med. 2016;8:153r–364r.
   Web of Science ®Google Scholar
• Manickam DS, Oupicky D. Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. Bioconjugate Chem. 2006; 17:1395–1403.
   PubMed Web of Science ®Google Scholar
• McKenzie DL, Smiley E, Kwok KY, et al. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjugate Chem. 2000;11:901–909.
   PubMed Web of Science ®Google Scholar
• Goodwin TJ, Huang L. Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis. Vaccine. 2017;35:2550–2557.
   PubMed Web of Science ®Google Scholar
• Xu Z, Ramishetti S, Tseng YC, et al. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. J Control Release. 2013;172: 259–265.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhu H, Liu Y, et al. BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunol Immunother. 2017 [Nov 1];[1–12]. doi: 10.1007/s00262-017-2079-7
   Web of Science ®Google Scholar
• Hu K, Miao L, Goodwin TJ, et al. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano. 2017;11:4916–4925.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kim WY, Huang L. Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy. Biomaterials. 2013;34: 3447–3458.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang Y, Ramishetti S, et al. Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate. J Control Release. 2013;170:414–420.
   PubMed Web of Science ®Google Scholar
• Lecaros RL, Huang L, Lee TC, et al. Nanoparticle delivered VEGF-a siRNA enhances photodynamic therapy for head and neck cancer treatment. Mol Ther. 2016;24:106–116.
   PubMed Web of Science ®Google Scholar
• Tseng YC, Xu Z, Guley K, et al. Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases. Biomaterials. 2014;35:4688–4698.
   PubMed Web of Science ®Google Scholar